Compare NetApp Inc. (NTAP) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetApp Inc. vs Recursion Pharmaceuticals Inc — how do they compare? NetApp Inc. trades at $166.94 (market cap $31.57B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: NetApp Inc. is far larger — about 20.6× Recursion Pharmaceuticals Inc's market cap, and NetApp Inc. pays a 1.29% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| NTAP | RXRX | |
|---|---|---|
Market Cap | $31.57B | $1.53B |
Sector | Technology | Health |
52-Week High | $181.08 | $6.79 |
52-Week Low | $94.11 | $2.84 |
Enterprise Value | $30.72B | $946.50M |
Dividend Yield | 1.29% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
